10/11/2024
Aducanumab is a newly approved drug for the treatment of mild Alzheimer’s disease. However, there are many risks associated with its use, such as swelling or bleeding.
Read more:
Aducanumab is a new medication for treating early dementia, or mild Alzheimer's disease. However, experts have concerns about its effectiveness. Learn more.